Ovarian cancer, often a "silent killer," is the 8th most common cancer in women globally and the third in India. Early ...

In 2013, Mary Lou Polo was given just a week to live. She had stage IV ovarian cancer, and her chances of survival were grim. This September, more than 10 years later, Polo recently celebrated her ...

Initial findings from the Every Woman Study™: Low- and Middle-Income Countries is published in The Lancet Obstetrics, ...

Ovarian cancer is treatable is detected early, but 70% of cases aren’t diagnosed until it’s too late. A promising blood test may change that. Each year, about 20,000 women are diagnosed with ovarian ...

Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ...

Immunonutritional status, assessed by PNI and SII, significantly influences ovarian cancer prognosis, affecting survival outcomes and chemotherapy tolerance. High PNI and low SII correlate with longer ...

Wistar Institute scientist Maureen Murphy wants to solve a decades-long mystery: Why is ovarian cancer often resistant to hormone therapy? In a recently published study, she shared a new theory as to ...

A Hudson Institute research project aiming to better understand and treat rare forms of ovarian cancer has received a big ...

Ovarian01 Phase 3 Trial of ENHERTU® Initiated as First-Line Maintenance Therapy in Patients with HER2 Expressing Advanced ...